C3, ASP, Complement C3, C3adesArg, C3bc, CPAMD1, C3 and PZP-like alpha-2-macroglobulin domain-containing protein 1, CO4, Basic complement C4, Complement C4-B, C3 and PZP-like alpha-2-macroglobulin domain-containing protein 3, C4B, CPAMD3, Vascular endothelial growth factor A, VPF, VEGFA, VEGF, Vascular permeability factor, VEGF-A
Niveau d'endotoxines
< 10 EU/mg
Pureté
>95% purity as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Numéro d'accès
P01024 & P0C0L5 & P15692
Forme
Liquid
Tampon de stockage
0.01M PBS pH 7.4
Reférez-vous aux informations spécifiques sur le tampon dans la copie papier du datasheet ou dans le COA spécifique au lot.
Stabilité et stockage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Noms alternatifs
ACVP-1, IBI302, IBI-302, IBI302, 2375661-82-6
Contexte
Efdamrofusp alfa is a bispecific fusion protein. Efdamrofusp alfa is capable of neutralizing both VEGF isoforms and C3b/C4b. Efdamrofusp alfa can be used for the research of neovascular age-related macular degeneration (nAMD) and other complement-related ocular conditions.
Note
For research use only. Not suitable for clinical or therapeutic use.
中文
English
한국어
日本語
Español
Français
Русский
